Lansoprazolo Tecnimede

Lansoprazole, the active ingredient in Lansoprazolo Tecnimede, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and related disorders in adult patients.

GNH USA supplies Lansoprazolo Tecnimede as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring quality and regulatory conformity across all markets. The company adheres to Good Distribution Practice, provides full documentation, and supports import logistics for institutional buyers.

Lansoprazole is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and prevents esophageal damage by reducing acid exposure. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence by maintaining a low‑acid environment. - Helicobacter pylori eradication: used in combination regimens to increase bacterial eradication rates. - Erosive esophagitis: heals mucosal injury and reduces symptoms through sustained acid suppression.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Nausea: mild nausea or stomach discomfort. - Abdominal pain: crampy discomfort in the abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: severe skin reactions with blistering. - Liver enzyme elevation: significant increase in hepatic transaminases.

When prescribing or dispensing lansoprazole, several safety considerations should be observed.

- Assess renal function: dose adjustment may be needed in severe renal impairment. - Review concomitant medications: avoid use with drugs requiring acidic gastric pH for absorption. - Monitor long‑term use: prolonged therapy may increase risk of fractures or vitamin B12 deficiency. - Use caution in pregnancy: benefits should outweigh potential risks; consult obstetric guidance. - Discontinue before surgery: consider stopping before procedures requiring gastric acidity. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Lansoprazole can affect the pharmacokinetics of several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced absorption leading to therapeutic failure. - Atazanavir: decreased plasma levels compromising antiviral efficacy. - Iron salts: diminished iron uptake causing anemia risk. - Mycophenolate mofetil: lowered exposure may reduce immunosuppression. - Warfarin: enhanced anticoagulant effect increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentration, monitor levels. - Methotrexate: possible accumulation, watch for toxicity. - Clopidogrel: reduced activation, may lessen antiplatelet effect. - Phenytoin: altered metabolism, monitor seizure control. - Calcium carbonate: may affect absorption of both agents.